Transplantation proceedings, vol.49, pp.454-459, 2017 (SCI-Expanded)
Background. Immunosuppressive regimens with tacrolimus or cyclosporine A (CsA) were compared for graft-related outcomes in conjunction with complement-binding de novo donor-specific antibodies (DSAs).